![Activated Clotting Time (ACT): Comparison of the Hemochron Signature E" by Lilah Evans, Susanne Gallo et al. Activated Clotting Time (ACT): Comparison of the Hemochron Signature E" by Lilah Evans, Susanne Gallo et al.](https://jdc.jefferson.edu/pacbposters/1004/preview.jpg)
Activated Clotting Time (ACT): Comparison of the Hemochron Signature E" by Lilah Evans, Susanne Gallo et al.
![Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR) | Semantic Scholar Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a903f52621bf7c85274745ed85f506a6557d8592/2-Figure1-1.png)
Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR) | Semantic Scholar
![Activated Clotting Time Testing Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research Activated Clotting Time Testing Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research](https://www.databridgemarketresearch.com/media/2021/5/a31e208d-a300-430d-a499-f17f16251b15.jpg)
Activated Clotting Time Testing Market – Global Industry Trends and Forecast to 2028 | Data Bridge Market Research
![Point-of-care testing of activated clotting time in the ICU: is it relevant? | British Journal of Nursing Point-of-care testing of activated clotting time in the ICU: is it relevant? | British Journal of Nursing](https://www.magonlinelibrary.com/cms/10.12968/bjon.2016.25.11.608/asset/images/medium/bjon.2016.25.11.608_t02.jpg)
Point-of-care testing of activated clotting time in the ICU: is it relevant? | British Journal of Nursing
![Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/2015-04/128521.png)
Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com
![JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures](https://pub.mdpi-res.com/jcm/jcm-10-04240/article_deploy/html/images/jcm-10-04240-g004.png?1632219399)
JCM | Free Full-Text | Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures
![Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2015-04/128521.png?itok=h5KwPjk7)
Activated Clotting Time (ACT) and Outcomes During PCI for NSTEMI: Insights from FUTURA OASIS-8 | tctmd.com
Activated Clotting Time Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022 - 2028 - MarketWatch
![Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of Heparin | Semantic Scholar Activated Clotting Time Versus Activated Partial Thromboplastin Time for Therapeutic Monitoring of Heparin | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9b0d925f3fd09d9064212c8db86a28600844337d/2-Table1-1.png)